Bye, bye blockbusters, hello niche busters

Collier, Roger
August 2011
CMAJ: Canadian Medical Association Journal;8/9/2011, Vol. 183 Issue 11, pE697
Academic Journal
The article presents suggestions on how pharmaceutical companies can re-drive their profits, when patents on blockbuster drugs expire across the world. It defines the concept of blockbuster philosophy, which has dominated the pharmaceutical industry and proposes that drugs should be developed for as many people as possible so as to achieve sales of at least one billion dollars. It highlights a parallel drug diagnostic model, which can increase the efficacy of pharmaceutical companies.


Related Articles

  • Vantage Point. McDonald, Susan Schwartz // Medical Marketing & Media;Feb2012, Vol. 47 Issue 2, p25 

    The article reports on a survey conducted to 156 leaders in the U.S. and Europe which reveals that 68% of respondents believed that the commercial pharmaceutical model is broken.

  • Local pharmaceutical drug sales reached $769 million in FY 2000, a 30% hike. Martinez, Marialba // Caribbean Business;11/23/2000, Vol. 28 Issue 46, p4 

    Reports the local pharmaceutical drug sales for the fiscal year 2000 in Puerto Rico. Cost estimates in the development of innovative drugs; Impact of existing tax incentives for research and development technology on pharmaceutical companies; Accounts of the Pharmaceutical Industry Association...

  • Pharmaceutical companies show 3Q gains. Martinez, Marialba // Caribbean Business;11/23/2000, Vol. 28 Issue 46, p14 

    Forecasts the earning growth in the pharmaceutical industry for fourth quarter of 2000 in Puerto Rico. Account on companies with the highest rating given by Multex Investor analysts; Selection of Cardinal Health as the most financially attractive firm in the industry; Names of companies with...

  • Reaching Your Customers Where They Live. Shababb, George // Medical Marketing & Media;Oct98, Vol. 33 Issue 10, p112 

    Discusses the effectiveness of using direct-to-customer services in the United States pharmaceutical industry. How the service can be enhanced; Marketing techniques used by companies; Factors which should be considered by manufacturers when spending money in mass mailings, co-marketing and...

  • GROUP SELLING TECHNIQUES AT CONVENTIONS PAY OFF. Konopacki, Allen // Medical Marketing & Media;May2000, Vol. 35 Issue 5, p110 

    Focuses on the benefits of United States-based pharmaceutical companies' practice of group selling techniques during medical conventions. High costs associated with one-to-one selling; Creation of consultative interactions with four to six physicians at a time; Reduction of representatives'...

  • Pharmaceutical sales continue strong growth momentum. Roller, Kim // Drug Store News;8/28/2000, Vol. 22 Issue 12, p36 

    Reports the strong sales of retail pharmaceuticals in the United States for year 2000. Drug categories that indicate strong sales; Financial earnings posted by drug companies for the second-quarter of the year.

  • DOJ sweep puts pharmas on high alert. Liebman, Milton // Medical Marketing & Media;Sep2003, Vol. 38 Issue 9, p9 

    Reports that several pharmaceutical companies have received a federal subpoena for documents related to marketing and sales practices in the United States. Merck & Co., Inc.; Johnson & Johnson Inc.; Bristol-Myers Squibb Co.

  • No Retreat, No Surrender: Winning Strategies of the Indian Pharmaceutical Industry. Singh, Abhinava S.; Das, Siddharth G. // BVIMR Management Edge;2011, Vol. 4 Issue 1, p33 

    This study of the Indian Pharmaceutical Industry attempts to identify existing and proposed business models for the choice of strategic options for the success of the Indian pharmaceutical industry in the Post Product Patent Regime. As part of the study, a number of company & industry reports,...

  • The Man in the Waiting Room. Maddy, Richard E. // Texas Heart Institute Journal;2014, Vol. 41 Issue 4, p355 

    A personal narrative is presented which explores the author's experience of working as a medical representative.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics